The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

"Overall, metabolic responses to glucagon stimulation in individuals with type 1 diabetes are comparable to those in healthy ...

The following is a summary of “Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls,” published ...

CHICAGO and ARLINGTON, Va. - The American Diabetes Association and a national supporter, Xeris Pharmaceuticals, have formed a multi-year strategic partnership to reinforce the importance of prescribin ...

Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...

The two organizations will produce educational materials about the medicine and its importance for people living with type 1 ...

Researchers from the Hebrew University of Jerusalem, Hadassah Medical Center, and the University of Pennsylvania found that the enzyme Glucose-6-phosphatase 2 (G6PC2) helps manage blood sugar levels ...

Severely low blood sugar usually requires a glucagon injection. Speak with a healthcare provider to learn ways to prevent low blood sugar if you have frequent episodes of hypoglycemia.

The research sheds new light on how this enzyme influences glucagon secretion in pancreatic alpha (α) cells, a process crucial for maintaining healthy blood sugar levels. The research ...

These data support our hypotheses that the glucagon response to hypoglycemia is reduced in patients who are approaching the insulin-deficient end of the spectrum of type 2 diabetes and that recent ...

insulin-induced hypoglycemia is associated with normal inhibition of endogenous insulin secretion and either defective or partially restored glucagon secretion, epinephrine secretion, and symptom ...